Professor David Price
Chair of Primary Care Respiratory Med
- 黑料网
-
- Email Address
- d.price@abdn.ac.uk
- Telephone Number
- +44 (0)1224 437237
- School/Department
- School of Medicine, Medical Sciences and Nutrition
- Publications
-
Page 3 of 40 Results 51 to 75 of 976
Burden of Type 2 and Oral Corticosteroids Related Comorbidities in Severe Asthma Patients from the Gulf Countries: A Comparative Study from The ISAR Registry
Journal of Asthma and Allergy, vol. 18, pp. 1879鈥�1891Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Novel insights into the comorbidity burden of severe asthma in Canada: Analysis of the Canadian Severe Asthma Registry
The ERS Congress 2025, PA3635Contributions to Journals: Abstracts- [ONLINE] DOI:
Derivation and definitions of clinical study variables for multiple long term conditions in patients with chronic obstructive pulmonary disease: Protocol for a modified Delphi methods and consensus study on behalf of the International Cardiovascular and Respiratory Alliance
Pragmatic and Observational Research, vol. 16, pp. 243鈥�251Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
CodeX effectively identifies high-risk patients with asthma or COPD in Dutch primary care, supporting guideline-driven treatment: Therapeutic Advances in Respiratory Disease
Therapeutic advances in respiratory disease, vol. 19, 17534666251329192Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Economic burden of asthma multimorbidity in Singapore: Shadow costs of steroid use
World Allergy Organization Journal, vol. 18, no. 12, 101146Contributions to Journals: Articles- [ONLINE]
- [ONLINE] DOI:
- [OPEN ACCESS]
Response to biologics along a gradient of T2 involvement in patients with severe asthma: a data-driven biomarker clustering approach
The Journal of Allergy and Clinical Immunology: In Practice, vol. 13, no. 12, pp. 3296-3315Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Are adults with COPD in Australian primary care at a greater risk of cardiovascular events than adults without COPD?
The ERS Congress 2025, PA1398Contributions to Journals: Abstracts- [ONLINE] DOI:
A time-clocked care pathway on severe asthma: A global consensus by Delphi methodology
The ERS Congress 2025, PA1414Contributions to Journals: Abstracts- [ONLINE] DOI:
Clinical profile of severe asthma (SA) patients Mexican vs Global data and evolution once in the international severe asthma registry (ISAR)
The ERS Congress 2025, PA5707Contributions to Journals: Abstracts- [ONLINE] DOI:
Extrafine beclometasone/formoterol is non-inferior to budesonide/formoterol as maintenance and reliever therapy (MART) for adult asthma patients and reduces the total carbon footprint of all inhaler-related greenhouse gas (GHG) emissions
The ERS Congress 2025, PA342Contributions to Journals: Abstracts- [ONLINE] DOI:
Long-term exacerbation trends before/after initiating triple therapy for uncontrolled asthma
The ERS Congress 2025, PA4637Contributions to Journals: Abstracts- [ONLINE] DOI:
Modelling the impact of earlier biologic initiation in severe asthma patients
The ERS Congress 2025, PA1387Contributions to Journals: Abstracts- [ONLINE] DOI:
Predicting long-term remission with benralizumab in severe eosinophilic asthma (SEA): Post-hoc analysis of SIROCCO, CALIMA, BORA
The ERS Congress 2025, PA2486Contributions to Journals: Abstracts- [ONLINE] DOI:
Disease Trajectory and Treatment Escalation in Asthma: A Retrospective Analysis of Data From the Optimum Patient Care Research Database (OPCRD)
Journal of Allergy and Clinical Immunology: In Practice, vol. 13, no. 11, pp. 2991-3001Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
- [ONLINE]
A 21-practice evaluation of an asthma and COPD quality improvement program
Journal of Asthma and Allergy, vol. 2025, no. 18, pp. 1599鈥�1613Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Clinical effectiveness of anti-inflammatory reliever therapies (AIR) for exacerbation prevention: a non-inferiority study
British Thoracic Society Winter Meeting 2025, pp. A328Contributions to Journals: Abstracts- [ONLINE] DOI:
Evaluation of participant experience in the NIHR HTA OPACE (optimising azithromycin prevention treatment in COPD to reduce exacerbations) trial: a pragmatic trial of continued vs discontinued azithromycin prophylaxis in COPD
British Thoracic Society Winter Meeting 2025, pp. A342Contributions to Journals: Abstracts- [ONLINE]
- [ONLINE] DOI:
The potential effect of glucagon-like peptide 1 receptor agonists (GLP1s) on chronic obstructive pulmonary disease (COPD) exacerbations, a case control analyses
British Thoracic Society Winter Meeting 2025, pp. A74-A75Contributions to Journals: Abstracts- [ONLINE] DOI:
Corticosteroid burden and potentially related comorbidities in severe asthma: insights from East and Southeast Asia
29th Congress of the Asian Pacific Society of Respirology, PS02-0917Contributions to Journals: Abstracts- [ONLINE] DOI:
- [OPEN ACCESS]
Effect of budesonide/glycopyrronium/formoterol fumarate dihydrate on cardiopulmonary outcomes in COPD: rationale and design of the THARROS trial
ERJ Open Research, vol. 11, no. 6, 00324-2025Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
- [ONLINE]
Changes in use and utilisation patterns of drugs with reported shortages between 2010 and 2024 in Europe and North America: a network cohort study
The Lancet Public Health, vol. 10, no. 10, pp. e835-e847Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Identification and management of cardiopulmonary risk in patients with COPD: a multidisciplinary consensus and modified Delphi study
European Journal of Preventive Cardiology, vol. 32, no. 15, pp. 1445鈥�1460Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Stratification of the Continuum of Skin Immune-Mediated and Inflammatory Diseases via an AI Foundation Model
American Association of Dermatology Annual Meeting 2025, pp. AB304Contributions to Journals: Abstracts- [ONLINE] DOI:
- [OPEN ACCESS]
- [ONLINE]
Clinical effectiveness of anti-inflammatory reliever therapies (AIR) for asthma control: a non-inferiority study
PCRS Respiratory Conference 2025, pp. ID 629Contributions to Conferences: Posters- [ONLINE]
Measuring the Impact of the CONQUEST COPD Quality Improvement Programme in UK Primary Care
PCRS Respiratory Conference 2025, pp. ID 709Contributions to Conferences: Posters- [ONLINE]